image: Professor Xiaoyuan (Shawn) Chen, Nasrat Muzayyin Chair Professor in Medicine and Technology, NUS Medicine.
Credit: NUS Medicine
Professor Xiaoyuan (Shawn) Chen, Nasrat Muzayyin Chair Professor in Medicine and Technology, Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), has been appointed the founding Editor-in-Chief of ACS Nano Medicine, a new peer-reviewed hybrid journal published by the American Chemical Society (ACS).
Set to begin accepting submissions in June 2025 and publish its inaugural issue in January 2026, ACS Nano Medicine will showcase significant research breakthroughs at the intersection of nanoscience, medicine, biology, chemistry, and materials. The journal aims to serve as a leading platform for research that applies nanotechnology to clinical diagnosis and therapeutics.
“Nanomedicine is unlocking new frontiers in the treatment of diseases once deemed untreatable, propelling us closer to the era of truly personalised medicine. I am energised to lead a journal dedicated to spotlighting the most transformative advances in the nanomedicine field,” said Prof Chen. “My vision is to catalyse collaboration and accelerate knowledge exchange across the global nanomedicine community, synergising with the work underway at NUS Medicine’s Nanomedicine Translational Research Programme.”
Prof Chen brings extensive experience and leadership to the role. In addition to directing the Nanomedicine Translational Research Programme and serving as Research Director at the Clinical Imaging Research Centre at NUS Medicine, he has authored over 1,000 peer-reviewed publications with more than 160,000 citations.
His research spans molecular imaging, drug and gene delivery, radiopharmaceuticals, and nanomedicine, with a particular focus on clinically translatable theranostics. Notably, his therapeutic radiopharmaceutical, 177Lu-LNC1004, has received approval from regulatory agencies in the US, Singapore, and China for the treatment of advanced solid tumours.
Professor Chen previously served as the founding editor of Theranostics and holds editorial roles across several scientific journals, including ACS Nano, Bioconjugate Chemistry, and Journal of Nuclear Medicine, among others. His international standing in the field has been recognised by numerous awards, including the Michael J. Welch Award from the Society of Nuclear Medicine and Molecular Imaging (2019) and the JNB Trailblazer Award (2023). He was also recently inducted into Academia Europaea and European Academy of Sciences, and elected to the Singapore National Academy of Science.